Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease

BACKGROUND: Indacaterol, a once-daily, long-acting β(2)-agonist, may improve not only respiratory function, dyspnea symptoms, and quality of life, but also physical activity for patients with chronic obstructive pulmonary disease (COPD). This study aimed to evaluate the effect of 12-week indacaterol...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishijima, Yu, Minami, Seigo, Yamamoto, Suguru, Ogata, Yoshitaka, Koba, Taro, Futami, Shinji, Komuta, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354394/
https://www.ncbi.nlm.nih.gov/pubmed/25767381
http://dx.doi.org/10.2147/COPD.S76836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354394/
https://www.ncbi.nlm.nih.gov/pubmed/25767381
http://dx.doi.org/10.2147/COPD.S76836

Ejemplares similares